GlassScriptPhysician profile
Ozgur Oztas
NPI 1174572747
$19,004.01
in general payments reported to CMS, 2019-2025
67 companies · $1,963 in 2025
The $1,963 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,457 · 2020: $2,698 · 2021: $3,944 · 2022: $3,621 · 2023: $3,073 · 2024: $1,248 · 2025: $1,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,255 · Education: $28.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,255.42 |
| Education | $28.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,627.16 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,957.24 | 2019-2025 | |
| Biogen, INC. | $1,099.00 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Ucb, INC. | $984.38 | 2019-2025 | Briviact, Zilbrysq, Fintepla |
| Acadia Pharmaceuticals INC | $876.35 | 2019-2025 | Nuplazid |
| Sk Life Science, INC. | $845.59 | 2020-2025 | |
| Amgen INC. | $841.37 | 2019-2025 | Uplizna, Aimovig |
| Genzyme Corporation | $778.27 | 2019-2025 | |
| Eisai INC. | $667.94 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $655.68 | 2019-2023 | Ultomiris |
| Emd Serono, INC. | $615.69 | 2019-2025 | Mavenclad |
| Lundbeck LLC | $547.39 | 2020-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $509.06 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $456.38 | 2019-2025 | Ingrezza, Ongentys |
| Celgene Corporation | $428.04 | 2021-2024 | Zeposia |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ozgur Oztas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.